Editorial: How to cut U.S. drug prices without hurting innovation
The price of Wegovy, Novo Nordisk’s blockbuster weight-loss drug, is $1,349 a month in the U.S.; in Germany, it’s $328. The U.S. price for Keytruda, a cancer treatment, is $191,000 a year; in Japan, it’s $44,000. The U.S. pays three times more for branded prescription drugs, on average, than other...